HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

J&J's Analgesic Sales Ease Pain Of Ongoing OTC Turnaround

This article was originally published in The Tan Sheet & The Rose Sheet

Executive Summary

CFO Dominic Caruso reaffirms J&J’s commitment to keeping and growing its consumer business as the firm reports its OTC adult analgesic US market share reached 14% while pediatric share was nearly 46%.

You may also be interested in...



Tylenol Relaunch Ads Harken To “Trusted” History

In online video ads for Tylenol, the firm says “for everything we do, we know you do so much more.” CFO Dominic Caruso says the ad campaign will reconnect the brand with consumers.

L’Oréal Partners With Microalgae Biotech For New Cosmetic Actives

French firms L’Oréal and Microphyt partner to drive development of cosmetic solutions based on the latter’s patented, low-carbon process for cultivating microalgae. Already, Microphyt markets three cosmetic ingredients based on microalgae bioactives for enhanced skin vitality and resilience.

‘The Search Is On’: PCPC’s Lamoriello On Replacing Microplastic In Cosmetics, Reasonable Deadlines

The European Commission should extend the proposed six-year deadline “significantly” for replacing microplastics in leave-on cosmetics such as sunscreens and nix microplastic labeling requirements for makeup, lip and nail products, says the Personal Care Products Council’s executive VP of global strategies Francine Lamoriello, calling the task before industry “huge.”

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

RS123014

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel